EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 27th, 2018 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations
THIS AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is made in Jerusalem as of this _ day of November 14, 2005 (the “Effective Date”).
MASTER SERVICES AGREEMENT FORMaster Services Agreement • November 27th, 2018 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations • Delaware
This MASTER SERVICES AGREEMENT (“Agreement”), effectively dated as of the last date of authorized signature herein (“Effective Date”), is made by and between BioCancell Therapeutics Israel Ltd. Together with its Affiliates (“Sponsor”), a company incorporated in Israel, with principal offices located at 1/3 High-Tech Village, Givat Ram, Jerusalem, Israel, PO Box 39264, Jerusalem 9139102, Israel and INC Research, LLC, together with its Affiliates (“INC Research”), a Delaware limited liability company, with principal offices located in the United States at 3201 Beechleaf Court, Suite 600, Raleigh, North Carolina 27604-1547.
